← Back to Search

Unknown

Sequence 1 for Healthy Female Volunteers

Phase 1
Waitlist Available
Research Sponsored by InventisBio Co., Ltd
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up single dose, 3 period, 3 treatment study separated by 14 day washout periods to evaluate safety and bioavailability. overall time in study is approximately 42 days.
Awards & highlights

Study Summary

Relative Bioavailability study of D-0502 tablet formulation in healthy female subjects

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~single dose, 3 period, 3 treatment study separated by 14 day washout periods to evaluate safety and bioavailability. overall time in study is approximately 42 days.
This trial's timeline: 3 weeks for screening, Varies for treatment, and single dose, 3 period, 3 treatment study separated by 14 day washout periods to evaluate safety and bioavailability. overall time in study is approximately 42 days. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Access the oral bioavailability of D-0502 100mg and 200mg tablets

Trial Design

6Treatment groups
Experimental Treatment
Group I: Sequence 6Experimental Treatment1 Intervention
3 period, 3 dose level
Group II: Sequence 5Experimental Treatment1 Intervention
3 period, 3 dose level
Group III: Sequence 4Experimental Treatment1 Intervention
3 period, 3 dose level
Group IV: Sequence 3Experimental Treatment1 Intervention
3 period, 3 dose level
Group V: Sequence 2Experimental Treatment1 Intervention
3 period, 3 dose level
Group VI: Sequence 1Experimental Treatment1 Intervention
3 period, 3 dose level
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
D-0502
2018
Completed Phase 1
~240

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

InventisBio Co., LtdLead Sponsor
19 Previous Clinical Trials
1,941 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Evaluation of Relative Bioavailability of D-0502 Tablet in Healthy Female Subjects
2021. "Evaluation of Relative Bioavailability of D-0502 Tablet in Healthy Female Subjects". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05226338.
~5 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top